Medico Remedies (MEDICO) Share Price Falls 9.06%: What Today’s Move Shows
- September 25, 2026
- Posted by: Harsh Piplani
- Category: News
Medico Remedies Share Price fell to Rs 29.71 today, down 9.06% from the previous close, with the company’s market capitalisation at Rs 271.11 crore. The latest move makes Medico Remedies one of the more closely watched names in the day’s stock news, even though the supplied data does not establish a company-specific catalyst. For investors scanning Medico Remedies Share Price Today, the important point is that the decline is entirely event-led and measurable: the stock moved from Rs 32.67 to Rs 29.71, which puts today’s price action in clear context. In Univest coverage, this is the kind of share price fall that merits a fresh look at valuation, sector positioning and the basic financial setup behind the move.
Medico Remedies Stock News today therefore revolves around facts rather than speculation. The stock is a Micro Cap, the turnover is Rs 0.23 crore, and the session closed well below the open. That combination makes Medico Remedies Share Price a useful case study in how quickly a single-day decline can change the tone of market discussion without any verified new trigger.
Medico Remedies (MEDICO) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 29.71 |
| Previous Close | Rs 32.67 |
| Today's Move | -Rs 2.96 (-9.06%) |
| Open | Rs 33.13 |
| High | Rs 33.13 |
| Low | Rs 29.6 |
| Turnover | Rs 0.23 crore |
| Market Capitalisation | Rs 271.11 crore |
| Market Cap Category | Micro Cap |
Medico Remedies Share Price Today reflects a clear intraday decline. The stock opened at Rs 33.13, matched the day high at Rs 33.13, and later slipped to a low of Rs 29.60 before closing at Rs 29.71. Against the previous close of Rs 32.67, the share price fall was Rs 2.96, or 9.06%. That means today’s move erased a meaningful portion of the prior day’s level in one session, while still keeping the closing price just above the day low.
From a trading standpoint, the gap between the open and close shows that the session moved steadily lower after the initial print. The exact turnover was Rs 0.23 crore, which is a factual value rather than a signal in itself. For a company in the Micro Cap category, the day’s action is important because it changes the near-term stock price reference point and resets attention around Medico Remedies Share Price News. The data confirms the decline, but it does not establish a company-specific reason for why the stock fell today. In Univest editorial terms, this is a straightforward price event that now needs to be read alongside the company’s earnings quality, valuation and sector context.
Medico Remedies (MEDICO) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 271.11 crore |
| P/E Ratio | 19.62x |
| P/B Ratio | 3.48x |
| ROE | 19.02% |
| ROCE | 23.28% |
| EPS | Rs 1.66 |
| Book Value Per Share | Rs 9.4 |
| Dividend Yield | 0% |
These numbers show that Medico Remedies Share Price is not moving in isolation from financial metrics. A P/E of 19.62 is below the sector median of 32.73 and well below the sector average of 49.58 in the supplied benchmark set. The P/B of 3.48 is above the sector median of 2.95 and below the sector average of 4.37. For Univest readers, that mix means the stock is neither detached from sector valuation patterns nor obviously cheap on every measure. The data supports a factual read: profitability ratios are healthy, earnings per share is positive, and book value is clearly defined. Medico Remedies Stock News therefore needs to be viewed through the lens of both price action and company financials.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 19.62x |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.58x |
| Benchmark P/E Range | 3.48x to 757.76x |
| Company P/B Ratio | 3.48x |
| Benchmark Median P/B | 2.95x |
| Benchmark Average P/B | 4.37x |
| Company ROE | 19.02% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.7% |
| Company ROCE | 23.28% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 271.11 crore |
| Benchmark Median Market Cap | Rs 804.62 crore |
| Benchmark Average Market Cap | Rs 14,476.05 crore |
Medico Remedies operates in Healthcare, within Pharmaceuticals & Drugs, and the supplied sector benchmark covers the same industry with 199 companies. This is important because Medico Remedies Share Price can be compared directly with a broad industry set rather than a narrow peer group alone. The company’s P/E of 19.62 sits below the benchmark median of 32.73 and below the benchmark average of 49.58. Its P/B of 3.48 stands above the benchmark median of 2.95 but below the benchmark average of 4.37.
On return metrics, Medico Remedies compares favourably on ROE and ROCE. Its ROE of 19.02% is above the benchmark median of 11.7% and above the benchmark average of 10.7%. Its ROCE of 23.28% is also above the benchmark median of 13.61% and above the benchmark average of 13.4%. In market-cap terms, the company’s Rs 271.11 crore is below the benchmark median of Rs 804.62 crore and far below the benchmark average of Rs 14,476.05 crore, which is consistent with the Micro Cap classification. For Medico Remedies Share Price Today, the sector data suggests that profitability ratios are comparatively solid even as the valuation picture remains mixed across P/E and P/B. Univest uses this kind of sector analysis to separate the day’s price event from broader industry context.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,47,475.97 | 36.76 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,54,763.56 | 87.25 | 14.45 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,423.19 | 86.07 | 20.91 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,16,658.07 | 26.08 | 4.37 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,11,484.47 | 33.65 | 3.23 | 11.83 | 16 |
Peer comparison helps place Medico Remedies Share Price in a practical frame. Among the supplied listed peers, Medico Remedies has the smallest market capitalisation at Rs 271.11 crore, well below Sun Pharmaceutical Industries at Rs 4,47,475.97 crore, Divi’s Laboratories at Rs 2,54,763.56 crore, Torrent Pharmaceuticals at Rs 1,89,423.19 crore, Zydus Lifesciences at Rs 1,16,658.07 crore and Cipla at Rs 1,11,484.47 crore. That makes the company materially smaller than every peer listed in the dataset.
Valuation-wise, Medico Remedies Share Price sits on a P/E of 19.62, which is below Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla from the supplied peer set. Its ROE of 19.02% is above Sun Pharmaceutical and Cipla, close to Divi’s Laboratories and Zydus Lifesciences, but below Torrent Pharmaceuticals and Lupin. ROCE at 23.28% is stronger than several peers in the broader data and above the company’s own sector median. Univest readers tracking Medico Remedies Stock News can use these comparisons to see how the company’s numbers stack up without making assumptions beyond the supplied data.
Why Investors Are Watching Medico Remedies
- Medico Remedies Share Price fell 9.06% today, from Rs 32.67 to Rs 29.71.
- The day’s open was Rs 33.13, the high was Rs 33.13 and the low was Rs 29.60.
- Market capitalisation is Rs 271.11 crore, and the company is classified as a Micro Cap.
- P/E is 19.62, P/B is 3.48, EPS is Rs 1.66 and book value is Rs 9.4.
- ROE is 19.02% and ROCE is 23.28%, with the sector benchmark showing 199 companies.
About Medico Remedies
Medico Remedies is part of Healthcare and operates in Pharmaceuticals & Drugs, according to the supplied classification. The company is being discussed here in the context of its listed share price, market capitalisation, valuation ratios and industry benchmark data. For readers following Medico Remedies Stock News, the core point is that today’s decline can be evaluated against a verified business classification and a structured sector comparison. Medico Remedies Share Price Today therefore sits at the intersection of company-specific market action and the wider healthcare segment in Univest coverage.
Track Medico Remedies Share Price on Univest
Use Medico Remedies (MEDICO) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Medico Remedies Share Price on Univest for live updates, price action, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also presents company pages that make it easier to compare Medico Remedies Share Price Today with sector peers and other stock news from the same industry.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Medico Remedies share price fall today?
Ans. Medico Remedies Share Price fell 9.06% today to Rs 29.71. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the decline. The previous close was Rs 32.67.
What is Medico Remedies share price today?
Ans. Medico Remedies Share Price Today closed at Rs 29.71. It fell from the previous close of Rs 32.67 after opening at Rs 33.13 and touching a day low of Rs 29.60.
What is Medico Remedies market capitalisation?
Ans. Medico Remedies has a market capitalisation of Rs 271.11 crore. The company is classified as a Micro Cap in the supplied dataset, which provides useful size context for Medico Remedies Share Price.
How does Medico Remedies compare on valuation?
Ans. Medico Remedies has a P/E ratio of 19.62 and a P/B ratio of 3.48. Its P/E is below the sector median of 32.73, while its P/B is above the sector median of 2.95.
What do Medico Remedies ROE and ROCE show?
Ans. Medico Remedies reports ROE of 19.02% and ROCE of 23.28%. Both are above the sector benchmark median and average, which adds useful context for Medico Remedies Stock News and company analysis.
What is Medico Remedies EPS and book value?
Ans. EPS is Rs 1.66 and book value per share is Rs 9.4. These figures help frame Medico Remedies Share Price against earnings attributable to each share and accounting net worth per share.
Does Medico Remedies pay a dividend?
Ans. The supplied dividend yield for Medico Remedies is 0. That means no dividend yield is reflected in the dataset, so Medico Remedies Share Price should be read mainly through price and valuation data.
How does Medico Remedies compare with sector peers?
Ans. Medico Remedies is much smaller than peers such as Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its valuation and return ratios can still be compared directly with those companies.
